St Helens Place - On Demand Availability of Intravenous Antibiotics
A Contract Award Notice
by NHS CHESHIRE AND MERSEYSIDE INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £2K
- Sector
- HEALTH
- Published
- 30 Apr 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
East Merseyside: Heath Pharmacy 18 Elephant Lane St Helens WA9 5QW
1 buyer
1 supplier
- Aim RX St Helens
Description
Participating pharmacies will provide an Intravenous Antibiotic stockholding service for the patients in St Helens. The aim of the service is to improve the care of patients who require intravenous therapy in the community by ensuring pharmacies have sufficient stock of appropriate IV antibiotics during core hours.
Total Quantity or Scope
NHS Cheshire and Merseyside ICB has awarded a 1 year contract via Direct Award A to AIM RX LTD, trading as Heath Pharmacy (FCR74). The contract commenced on the 1st April 2025 and will expire on the 31st March 2026. The contract value is estimated to be £1680.00. This contract is an activity based contract and funding is based on delivery of the activity outlined within the service specification.
Award Detail
1 | Aim RX (St Helens)
|
Award Criteria
No realistic alternative provider | 99 |
price | 1 |
CPV Codes
- 85100000 - Health services
Legal Justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. On the 19th of November 2024 the Finance, Investment, Resources Committee approved this decision. One committee member has a standing declaration of interest. The decision to award was made in line with the Conflict of Interest policy.
Reference
- ocds-h6vhtk-050adb
- FTS 018220-2025